IOL Chemicals and Pharmaceuticals Ltd (IOLCP), a leading manufacturer of pharmaceutical APIs and specialty chemicals, has announced its unaudited financial results for the quarter ended 30th June 2025.
Standalone Q1 FY26 Financial Highlights (₹ in Crore)
Particulars | Q1 FY26 | Q4 FY25 | % QoQ | Q1 FY24 | % YoY |
Total Income | 559.06 | 532.30 | 5.0 | 509.76 | 9.7 |
EBITDA | 63.54 | 61.40 | 3.5 | 58.23 | 9.1 |
EBITDA Margin (%) | 11.4% | 11.5% | -10 bps | 11.4% | 0 bps |
PAT | 33.96 | 31.62 | 7.4 | 29.68 | 14.4 |
PAT Margin (%) | 6.1% | 5.9% | 20 bps | 5.8% | 30 bps |
Key Business Updates for the Quarter
- Overseas Expansion: Formation of a wholly owned subsidiary in the United Kingdom to strengthen presence in the UK and EU markets and enable better customer access.
- New Project Announcement: The Company has approved the establishment of Unit 9B, carved out from the existing Unit 9, dedicated to manufacturing Minoxidil and its intermediates. The unit will have an installed capacity of 120 MTPA, with a planned capital expenditure of ₹5.5 crore, fully funded through internal accruals. Completion is expected by December 2025.
About IOL Chemicals and Pharmaceuticals Limited (IOLCP)
Established in 1986 and listed on the National Stock Exchange of India Ltd (Code: IOLCP) and BSE Ltd (Code: 524164), IOL Chemicals and Pharma is one of the leading pharmaceutical (APIs) Companies and a significant player in the specialty chemicals space with world-class facilities. IOLCP has a wide presence across major therapeutic categories like pain management, anti-convulsants, anti-diabetes, anti-cholesterol and anti-platelets.
The Company's product portfolio includes APIs; Ibuprofen, Metformin, Fenofibrate, Clopidogrel, Lamotrigine, Pantoprazole, Paracetamol and specialty chemicals such as Ethyl Acetate, Iso Butyl Benzene, Mono Chloro Acetic Acid and Acetyl Chloride.
The company is the World's largest producer of Ibuprofen with an installed capacity of 12,000 TPA and having backward integrated manufacturing facility. The Company has DSIR-approved R&D which is fully equipped to validate existing processes.
The Central and State Government approved Effluent Treatment Plant (ETP) had been set up with Zero Liquid Discharge (ZLD) system along with a 17 MW captive Co-Generation plant for self-reliance. The Company is ISO 9001:2015, 14001:2015 and BS OHSAS 18001:2007 certified.
IOLCP's overseas customers are spread out across several countries including the UK, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland, Poland, Ireland, USA, Peru, Brazil, Argentina, Colombia, Indonesia, South Korea, Thailand, Bangladesh, Turkey, U.A.E., China, Hong Kong, Egypt etc. Products are sold primarily to Branded Generic formulators both in India & Overseas.
.jpg)